The influence of spray drying parameters on the phase behavior, drug distribution and in vitro release of injectable microspheres for sustained release by Meeus, Joke et al.
1 
 
The influence of spray drying parameters on phase behaviour, drug distribution and in 
vitro release of injectable microspheres for sustained release 
 
Joke Meeus1, Maité Lenaerts1, David J. Scurr2, Katie Amssoms3, Martyn C. Davies2, Clive J. 
Roberts2, Guy Van den Mooter1 
 
1Drug Delivery and Disposition, KU Leuven, Leuven, Belgium  
2Laboratory of Biophysics and Surface Analysis, School of Pharmacy, The University of 
Nottingham, NG7 2RD, Nottingham, United Kingdom  
3Pharmaceutical Companies of Johnson & Johnson, Discovery Sciences, PD&S_PDM, 
Beerse, Belgium 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
ABSTRACT  
For ternary solid dispersions it is indispensable to characterize their structure, phase behaviour 
and the spatial distribution of the dispersed drug as this might influence the release profile 
and/or stability of these formulations. This study shows how formulation (feed concentration) 
and process (feed rate, inlet air temperature and atomizing air pressure) parameters can 
influence the characteristics of ternary spray-dried solid dispersions. The microspheres 
considered here consist of a poly(lactic-co-glycolic acid) (PLGA) surface layer and an 
underlying polyvinylpyrrolidone (PVP) phase. A poorly soluble active pharmaceutical 
ingredient (API) was molecularly dispersed in this matrix. Differences were observed in 
component miscibility, phase heterogeneity, particle size, morphology as well as API surface 
coverage for selected spray drying parameters. Observed differences are likely due to changes 
in the droplet generation, evaporation and thus particle formation processes. However, 
varying particle characteristics did not influence the drug release of the formulations studied, 
indicating the robustness of this approach to produce particles of consistent drug release 
characteristics. This is likely due to the fact that the release is dominated by diffusion from the 
PVP layer through pores in the PLGA surface layer and that observed differences in the latter 
have no influence on the release. 
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INTRODUCTION  
Injectable sustained release formulations offer multiple advantages for the treatment of 
chronic diseases. Side effects of drugs with a narrow therapeutic window can be limited and 
importantly the administration frequency can be reduced to significantly improve patient 
compliance. This is expedient in the treatment of chronic diseases and crucial for the therapy 
of viral infections like those with the human immunodeficiency virus (HIV). In this case 
controlled release of the drug assures minimal inhibitory drug concentrations and thereby 
avoids the development of viral resistance. Additionally the sustained release of appropriate 
amounts of drug resulting in constant low drug plasma concentrations is sought-after for HIV 
pre-exposure prophylaxis. Different injectable sustained release formulations are already 
marketed. For example Trelstar® Depot (Debio RP),1 Sandostatin LAR® (Novartis 
Pharmaceuticals),2 and Risperdal®Consta® (Janssen)3 which are based on the biodegradable 
polymer  poly(lactic-co-glycolic acid) (PLGA) as a carrier.  
 
We previously reported on the development of spray-dried polymeric microspheres for 
intramuscular injection for the long-term prophylaxis of infection with HIV.4,5  These shell 
structured microspheres consist of two biocompatible polymers, water-insoluble poly(lactic-
co-glycolic acid) (PLGA), and water-soluble polyvinylpyrrolidone (PVP). It was 
hypothesized that the function of the PLGA in the formulation is to form a phase separated 
surface layer so as to provide the required slow release characteristics of the formulation. The 
underlying PVP phase was used to increase the solubility and dissolution rate of a poorly 
soluble active pharmaceutical ingredient (API) by forming a solid dispersion. A model 
formulation was prepared by spray drying where the resulting microspheres consisted of a 
ternary solid dispersion API/PLGA/PVP 30/25/45 wt%. The model drug used was a poorly 
soluble HIV protease inhibitor.  
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Various studies and reviews have already discussed the influence of spray drying parameters 
on the resulting pharmaceutical product.6-15 The majority of these studies describe how 
various spray drying parameters influence particle size and morphology6,9,10 and/or investigate 
binary systems.11-15 In contrast to previous work, the present study focusses on how spray 
drying parameters (both process and formulation) effect phase behaviour and spatial drug 
distribution of ternary solid dispersions and the consequences for in vitro release behaviour of 
these systems. Phase behaviour and spatial drug distribution can be decisive for the release 
characteristics of a formulation. For example, phase behaviour might influence the release, as 
particles containing a poorly soluble drug in the form of amorphous precipitates in the 
polymeric matrix are likely to have a slower release compared to ideal glass solutions where 
the drug is molecularly dispersed within a matrix. Spatial drug distribution might also 
influence the observed release. For instance, when a drug-rich phase containing a poorly 
soluble drug is exposed to a dissolution medium, the dissolution will be drug-controlled, 
characterized by slow dissolving of the drug, compared to a faster dissolving polymer. In 
contrast in a glass solution the release will be controlled by the dissolution of the polymer.8,16  
 
For the current study feed concentration was selected as a formulation parameter, whereas 
feed rate, inlet air temperature and atomizing air pressure were the process parameters tested. 
The particle size and morphology, phase behaviour and API surface coverage of the resulting 
microspheres were then characterized. The drug surface coverage is defined by the API 
distribution throughout the microspheres and hence can be used as an indicator for the latter. 
In this study a variety of complementary techniques were used to characterize the spray-dried 
samples. Firstly the phase behaviour of three model formulations was studied by means of 
modulated differential scanning calorimetry (MDSC). Secondly we examined the chemical 
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composition of the sample surface by time-of-flight secondary ion mass spectrometry (ToF-
SIMS). Other factors which might influence the release, such as particle size17-19 and surface 
morphology (e.g. smoothness, porosity)19 were studied via scanning electron microscopy 
(SEM). Release experiments were performed in a surfactant containing phosphate buffer at 
pH 7.  
    
In these complex ternary systems (API/PLGA/PVP) it is indispensable to have an insight into 
the structure of the binary polymeric matrix and the spatial distribution of the API as this 
might influence the release profile and/or stability of these formulations. Additionally, the 
findings of the present study were used to elucidate the underlying release mechanism of 
these ternary API/PLGA/PVP microspheres.  
 
EXPERIMENTAL SECTION 
Materials 
Poly(lactic-co-glycolic acid) (PLGA) (lactide:glycolide molar ratio of 75:25, inherent 
viscosity of 0.2 dl/g) was purchased from PURAC Biomaterials (Gorinchem, The 
Netherlands). Polyvinylpyrrolidone K30 (PVP K30) (MW 44-54 kDa) was kindly donated by 
BASF (Ludwigshafen, Germany). The API was a poorly soluble investigational compound 
provided by Janssen (Beerse, Belgium).  Disodium hydrogenphosphate dodecahydrate 
(Na2HPO4.12H2O) and formic acid were provided by Chemlab (Zedelgem, Belgium). Sodium 
hydrogenphosphate monohydrate (NaH2PO4.H2O) was supplied by Merck (Darmstadt, 
Germany). Acros Organics (Geel, Belgium) supplied dimethylformamide (DMF) and 
ammonium formiate. Polysorbate 80 (Tween 80) was obtained from Alfa Aesar GmbH 
(Karlsruhe, Germany). Polyethyleneglycol 400 (PEG) was purchased from Fagron (Waregem, 
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Belgium). Dichloromethane (DCM) and acetonitrile (ACN) were provided by Fisher 
Scientific (Leicestershire, United Kingdom). All solvents used were of HPLC or analytical 
grade. Ultrapure water was produced with an Elga Maxima system (Elga Ltd. High Wycombe 
Bucks, United Kingdom).  
 
Methods  
Spray drying 
All samples were spray dried with a Micro Spray lab scale spray dryer (ProCepT, Zelzate, 
Belgium) starting from a feed solution in dichloromethane (DCM) and with a constant co-
current drying air with a flow rate of 0.2 m³/min. 
The model formulation, API/PLGA/PVP 30/25/45 wt%, was spray dried with varying 
formulation and process parameters. Feed concentration was selected as a formulation 
parameter, whereas feed rate, inlet air temperature and atomizing air pressure were the 
process parameters tested. Each parameter studied was evaluated at a low and a high level 
with all other parameters at the middle level (reference). Samples were compared to a 
reference sample (middle level) (Table 1). Three reference samples were independently spray-
dried (Reference A, B and C). 
The binary samples API/PLGA and API/PVP were spray dried under the same conditions as 
the reference samples.  
 
Physical mixtures 
Physical mixtures of amorphous spray-dried PVP K30 and API were prepared according to 
the rules of geometrical blending using a mortar and pestle. 
 
In vitro drug release  
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Release experiments were performed at room temperature in rotating test tubes (17 rpm) 
containing an amount of the spray dried powders corresponding to an API dose of 0.6 mg in 
40.0 mL release medium. In this way sink conditions were assured throughout the experiment. 
The dissolution medium consisted of phosphate buffer at pH 7 containing 0.25% Tween 80 
and 2.5% PEG 400. Samples were collected at 5, 15, 30, 60 and 240 minutes, filtered over a 
Chromafil RC-20/15 cellulose acetate filter with a pore size of 0.2 µm (Macherey-Nagel, 
Düren, Germany) and subsequently analysed by high performance liquid chromatography 
(HPLC) with UV detection. Experiments were performed in triplicate. 
 
Solubility determination 
The solubility of the API in an aqueous solution without PVP as well as in presence of 0.5, 1, 
2 and 5 % PVP K30 was determined. Therefore 10 mL of the polymer solution was 
transferred into a test tube and an excess amount of API was added. These tests were 
performed at room temperature and test tubes were rotated for 48 hours at 17 rpm. 
Subsequently these samples were filtered over a Chromafil RC-20/15 cellulose acetate filter 
with a pore size of 0.2 µm and analyzed by HPLC with UV detection. Experiments were 
performed in triplicate. 
 
High performance liquid chromatography (HPLC) assay  
A Waters HPLC system (Milford, USA) consisting of a Waters 1525 Binary HPLC pump, a 
Waters 717plus Autosampler, set at a 10 μl injection volume, and a Waters 2487 Dual 
Lambda Absorbance detector, set at a detection wavelength of 255 nm, were used to quantify 
drug release. A Waters Sunfire C18 3.5 µm (4.6 mm × 100 mm) column was utilised. 
Samples were injected in duplicate and analyzed using a 1.0 mL/min flow rate at room 
temperature. The average result of both injections was reported. The mobile phase consisted 
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of a 50 mM formiate buffer (pH 4) and acetonitrile (57/43, v/v). The pH was measured using 
a WTW 330i pH meter (Weinheim, Germany). The buffer was filtered over a 0.45 µm 
polytetrafluoroethylene (PTFE) filter and the mobile phase was degassed prior to use. 
Standard curves were made in dimethylformamide (DMF) and were linear over the 
concentration range used (1.56-100 µM). Data were analyzed using Breeze software Version 
3.30 (Waters).  
 
Statistical analysis 
For each time point (5, 15, 30, 60, 120 and 240 min) statistical differences between the 
observed in vitro release were evaluated for all samples via one-way ANOVA. A Bonferroni 
post-hoc test was performed at an α level of 0.05. (GraphPad Prism 5 for Windows; GraphPad 
Software Inc., San Diego, USA). 
 
Modulated differential scanning calorimetry 
The bulk phase behaviour of the spray-dried microspheres was determined by MDSC (Q2000, 
TA Instruments, Leatherhead, UK). Thermal Analysis Software (Version 4.4A) was used to 
analyze the obtained data. Crimped aluminum pans (TA Instruments, Brussels, Belgium) were 
selected for the analysis of the samples. An empty pan was used as a reference and the masses 
of the reference pan and of the sample pans were taken into account. The DSC cell was 
purged with a nitrogen flow rate of 50 mL/min.  
Indium and n-octadecane were used for temperature calibration. The enthalpic response was 
calibrated with indium. The modulation parameters used were: a heating rate of 1°C/min, a 
period of 40 s and an amplitude of 1°C. Calibration of the heat capacity was done using 
sapphire. Samples were analyzed from -20°C to 220°C. Glass transitions were analyzed in the 
reversing heat flow signals. 
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Scanning electron microscopy 
SEM was used to gain insight into the morphology and particle size of the samples which 
were prepared by fixing an amount of powder on an aluminum stub using double-sided 
carbon tape. The samples were coated with a gold-palladium mixture by sputtering for 45 s at 
20 mA. Field emission gun scanning electron micrographs (FEG-SEM) were taken by using a 
Philips XL30 ESEM-FEG instrument (Philips, Eindhoven, The Netherlands) at an 
acceleration voltage of 10 kV.  
 
Time-of-flight secondary ion mass spectrometry 
Spray-dried samples were adhered to double-sided adhesive tape in order to produce an 
immobile surface suitable for ToF-SIMS analysis. The data were acquired using a ToF-SIMS 
IV instrument (ION-TOF GmbH) equipped with a bismuth liquid metal ion gun and a single-
stage reflectron analyzer. Typical operating conditions utilised a 25 kV Bi3+ primary ion 
source with a pulsed target current of approximately 0.3 pA. A flood gun producing low 
energy electrons (20 eV) was used to compensate for surface charging caused by the 
positively charged primary ion beam on the insulating sample surface. A 4 mm × 4 mm area 
of each sample was raster scanned at a resolution of 100 pixels per mm. PLGA and PVP were 
identified using C6H7O4- (m/z = 143), and C5H8O- (m/z = 84) respectively. The API was 
characterized by C5H11SO5- (m/z = 183). Prior to sample analysis, reference materials were 
analyzed and the characteristic ion peaks C6H7O4-, C5H8O- and C5H11SO5- were selected and 
only present in PLGA, PVP and API respectively. Negative polarity ToF-SIMS spectra 
showing the markers for API, PLGA and PVP are shown in Figure 1 of the Supporting 
Information. Static conditions were ensured by keeping the total primary ion beam dose for 
every analyzed area below 1 × 1012ions/cm² throughout the analysis. Data in the negative 
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secondary ion polarities were collected and analyzed using SurfaceLab 6 software (IONTOF). 
The data were acquired using the 'high current bunched’ setting on the instrument to achieve 
high mass resolution. For any given sample, the measured secondary ion intensity for each 
polymer marker peak was normalized to the total intensity count to enable a semi-quantitative 
comparison of the different samples. 
 
 
RESULTS 
1. Influence of spray drying parameters on particle characteristics and in vitro 
release 
Morphological characterization 
Particle size and morphology of samples produced by varying spray drying parameters was 
evaluated by SEM. Although a statistically significant number of particles were not analyzed, 
SEM could be used as an indicator for both particle size and morphology. Both parameters 
demonstrated to be comparable for all samples with the exception of the sample prepared 
from a feed solution with a concentration of 1% (Fig. 1). Particles spray-dried from a 1% feed 
concentration (the low level for this parameter, Table 1) appeared to be smaller and had a 
‘shriveled’ morphology. This was in contrast to samples spray-dried under all other conditions 
(Table 1) which exhibited spherical particles, with a smooth, intact surface and an estimated 
diameter approximately between 2 µm and 7 µm (Fig. 1). 
 
Miscibility 
MDSC was used to thermally characterize the pure compounds as well as the miscibility 
behaviour of the spray-dried microspheres. The spray-dried pure compounds were identified 
by their glass transition temperature (Tg) being approximately 38°C, 56°C and 174°C for the 
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PLGA, API and PVP respectively under the given experimental conditions. MDSC was 
utilized to study the bulk miscibility of the spray-dried samples through their Tgs, which were 
observed in the reversing heat flow curves (Fig. 2 and Table 2). For each sample two mixing 
Tgs were observed, the first one approximating to the Tg of PLGA and the second one shifting 
towards the Tg of pure PVP (Fig. 2). The Tg of the API (around 56°C) was not observed in the 
thermograms. 
In order to study the influence of various spray drying conditions not only the observed 
temperature values for the Tgs were evaluated but also the width of the Tg range was 
evaluated. The width of the Tg range provides information regarding the heterogeneity of the 
amorphous phase whereby the broader the Tg range, the more heterogeneous the 
amorphous.20-22 Differences in Tg values and the width of the Tg ranges were observed for 
various samples (Table 2). As preliminary studies demonstrated the high reproducibility of the 
MDSC measurements only one measurement per sample was carried out. The formulations 
spray-dried with a feed concentration of 1% or an atomizing air pressure of 1.5 bar resulted in 
a broader Tg range for the PLGA-rich phase (Tg1). The formulation spray-dried with a feed 
concentration of 1% showed a higher Tg of the PVP-rich phase (Tg2). Samples prepared with a 
feed rate of 10 mL/min or an atomising air pressure of 1.5 bar showed a broader Tg range for 
the PVP-rich (Tg2) In contrast, the sample spray-dried with a feed concentration of 10% 
resulted in a narrower Tg range for the PVP-rich phase (Table 2).  
 
API surface coverage 
The API surface coverage of the samples was compared by ToF-SIMS. The spatial 
distribution of the API and PLGA at the sample surface of a reference formulation and the 
formulation prepared with a feed concentration of 1% is represented in Figure 3. A negligible 
amount of PVP is detected at the particle surface, which corresponds with previous studies.4-5 
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At the micron-scale spatial resolution of the ToF-SIMS data acquired the drug appears to be 
homogeneously distributed at the surface of the three model formulations, illustrated by the 
absence of separate bright red (API) spots. Figure 4 shows the measured API intensity 
(normalized to total counts) at the sample surface and hence depicts a relative measure of API 
surface coverage for the various formulations. It is clear that one sample has a higher presence 
of API at the microsphere surface, namely the sample spray-dried with a low feed 
concentration (1%).  
 
Release behaviour 
In vitro release testing showed no significant differences for formulations spray-dried under 
the selected formulation and process parameters. Release profiles of samples produced under 
these varying conditions (Table 2) were compared to those of the three independently spray-
dried reference samples. The release behaviour of selected formulations is depicted in Figure 
5. Statistical differences between the observed release of the various samples were evaluated 
via ANOVA for each time point (5, 15, 30, 60, 120 and 240 min). The only statistical 
significant difference observed was at the first time point (5 min) for the sample spray-dried 
with a low feed rate (2 mL/min). This sample had at this point a lower release compared to all 
other samples. 
 
2. Elucidation of the release mechanism 
Function of PLGA  
To confirm the role of PLGA in the formulation (API/PLGA/PVP 30/25/45 wt%), binary 
formulations consisting of API/PLGA 10/90, 20/80 and 30/70 wt% were spray dried. MDSC 
analysis showed one mixing Tg for each of the formulations. The value of this Tg increased 
with increasing API content (Fig. 6A). In vitro release testing gave comparable results for the 
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three formulations (Fig. 7A). After five minutes averagely 4.2% (± 0.3%) of the API was 
released. This percentage did not significantly increase in the further course of the experiment 
with a total average drug release of ± 4.9% (± 0.8%) after four hours. 
 
Function of PVP 
To assess the role of PVP in the formulation, binary formulations consisting of API/PVP 
10/90, 20/80 and 30/70 wt% were spray dried. Again, MDSC analysis showed one mixing Tg 
for each of the formulations with a decreasing value of the observed Tg as API content 
increases (Fig. 6B). Formulations API/PVP 20/80 and 30/70 wt% showed a release 
comparable to the ternary formulation (API/PLGA/PVP 30/25/45 wt%) (Fig. 7B). 
Formulation API/PVP 10/90 wt% demonstrated a higher initial release but had a comparable 
cumulative drug release after four hours. 
Additionally the influence of the presence of PVP was investigated by performing release 
tests on physical mixtures of spray-dried API and PVP. The following mixtures were tested, 
API/PVP 10/90, 20/80 and 30/70 wt%. After four hours these physical mixtures had released 
a similar amount of drug compared to the spray-dried ternary formulation (API/PLGA/PVP 
30/25/45 wt%) (Fig. 7C). The observed difference in release is the absence of a burst release 
for the physical mixtures. Furthermore the influence of the presence of PVP upon the 
solubility of the API was assessed. These results are shown in Figure 2 of the Supporting 
information, where drug solubility is depicted as a function of the percentage of PVP present. 
This graph illustrates the linear increase in API solubility with an increasing amount of PVP 
present. The initial aqueous solubility of this drug was 0.018 mg/mL. This value increased up 
to 0.045 mg/mL after addition of 5% of PVP K30. 
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DISCUSSION 
1. Influence of spray drying parameters on particle characteristics and in vitro 
release 
The influence of various spray drying parameters on particle morphology and size was 
investigated. These are important sample characteristics as particle morphology influences 
decisive powder characteristics such as flowability and powder density.23-25 Particle size has 
already repeatedly been reported as having an influence upon release behaviour of 
microspheres.17-19  
Microspheres spray-dried from a feed concentration of 1% differed from all other samples, 
with a smaller particle size and ‘shriveled’ morphology. The reduction in particle size may 
originate from a decreased viscosity of the feed solution compared to the other samples as 
well as from a later solidification from droplet into particle.  
Viscosity of a solution is determined by the identity and concentration of compounds 
dissolved. For a given solute-solvent system a lower concentration results in a lower viscosity 
of that solution. When spray drying, viscosity of the feed solution will determine droplet size 
during the atomization process and therefore the particle size of the final particles. The lower 
the viscosity the smaller the droplets and resulting particles.8,26,27  
Additionally, the lower the concentration of a compound in the feed solution, the further it 
will be from its solubility limit and the longer it will take to reach the solidification point 
during the particle formation process. This results in a longer evaporation time with smaller 
droplets and hence smaller particles as a potential result.8 
 
MDSC was used to thermally study the phase behaviour of all samples. Preceding work has 
already shown that spray drying a formulation composed of API/PLGA/PVP 30/25/45 wt% 
results in hollow spheres with a PLGA-rich surface layer (containing small amounts of PVP), 
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an underlying PVP-rich layer (containing small amounts of PLGA) and a molecular 
dispersion of the API in these polymeric layers.4,5  
The present study confirms these findings by the observation of two mixing Tgs for all 
samples, the first one approximating the Tg of PLGA and the second one shifting towards the 
Tg of pure PVP (Fig. 2 and Table 2). In addition, the absence of a Tg around 56°C (Tg of the 
API) indicates that the API is molecularly dispersed in a phase separated system made up of a 
PLGA-rich phase and a PVP-rich phase. We want to remark that the expression “molecular 
dispersion” based on DSC data does only take into account heterogeneity/homogeneity above 
ca. 30 nm domain size. 
 
MDSC demonstrated that changing spray drying parameters not only affects the glass 
transition temperature (Tg)  but also the width of the Tg range (ΔTg) (Fig. 2, Table 2). 
The formulations spray-dried with a feed concentration of 1% or an atomising air pressure of 
1.5 bar resulted in a broader Tg range for the PLGA-rich phase indicating a more 
heterogeneous PLGA phase for these samples compared to the reference samples. Moreover, 
the sample spray-dried with a feed concentration of 1% showed a higher Tg of the PVP-rich 
phase. This might indicate a lower presence of PLGA and/or API in this phase as these 
compounds have a plasticizing effect on the PVP phase due to their lower Tg. Samples 
prepared with a feed rate of 10 mL/min or an atomising air pressure of 1.5 bar showed a 
broader Tg range for the PVP-rich phase indicating a more heterogeneous PVP phase for these 
samples compared to the reference samples. In contrast, the narrower Tg range for the PVP-
rich phase of the sample spray-dried with a feed concentration of 10% implies a more 
homogeneous PVP phase for this sample. These observations clearly indicate that varying 
spray drying parameters influences component miscibility and phase heterogeneity of the 
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samples. This might have consequences for release behaviour and stability performance of 
these formulations. 
 
Surface characteristics such as API surface coverage might also significantly influence the 
behaviour of the formulation, both in terms of release characteristics and stability. Therefore, 
ToF-SIMS was used to analyse the surface of the different spray-dried samples. The results 
indicated that only the sample spray-dried with a feed concentration of 1% contained a 
significantly higher amount of API at the microsphere surface compared to the reference. 
It was already noted that the viscosity of the feed solution influences particle size. 
Additionally feed viscosity can influence the distribution of a compound throughout the 
particle and hence surface coverage. The Stokes-Einstein equation (equation 2) shows the 
influence of viscosity on the diffusion coefficient of a compound and hence on its distribution 
in the spray-dried particle.8 
 
D = kBT / 6πηr   (2) 
 
In this equation D is the diffusion coefficient, r the globular radius, T the absolute temperature 
and η the viscosity of the solution. kB is the Boltzmann constant.  
The lower the concentration of a compound in the feed solution the further it will be from its 
solubility limit and the longer it will take to reach the solidification point during the particle 
formation process.8 This possible difference in solute deposition time might also influence the 
spatial distribution of the compounds and potentially causes the observed increase in API 
surface coverage for the sample spray-dried with a lower feed concentration. 
Another hypothesis is that migration of the API to the sample surface might be more 
pronounced for this sample because of the slower droplet evaporation and hence particle 
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formation. Evidence of preferential migration of a compound towards the droplet-air interface 
exists, where studies have reported surface segregation of apolar side groups at a polymer/air 
interface, including non-polar methyl side groups as present in PLGA.4,28-31 The same 
mechanism of surface restructuring might occur in the spray-dried particles and account for 
the increased presence of API at the particle surface. 
 
These findings are also complementary with the MDSC data where it was observed that the 
sample spray-dried from a 1% feed concentration possessed a higher Tg for the PVP-rich 
phase compared to the reference sample. It can now be confirmed that this is most likely due 
to the lower amount of drug present in the PVP phase of this sample. Analogously the more 
heterogeneous PLGA phase, characterized by a broader Tg range, can be ascribed to the 
increased presence of API in the PLGA layer of this sample. 
 
For the investigated spray drying parameters it is observed that feed concentration is the most 
determinative parameter and must therefore be controlled most rigorously. A low feed 
concentration resulted in smaller, differently shaped particles with divergent phase behaviour 
and enrichment of the drug at their surface. These different characteristics might have 
consequences for the behaviour of the formulation, with respect to both release and stability. 
 
Release behaviour 
Besides the influence of varying spray drying parameters on particle characteristics, the 
influence upon release behaviour of the resulting formulations was investigated and compared 
to that of three independently spray-dried reference samples. In vitro release testing showed 
that even when microsphere characteristics were influenced by varying the spray drying 
parameters this was overall not reflected in significant differences in their release profiles 
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(Fig. 5). In order to explain these observations the underlying release mechanism was 
investigated. To do so additional release testing of binary API/PVP and API/PLGA 
formulations, as well as of physical mixtures of API and PVP was performed to gain insight 
in to role of PLGA and PVP in these formulations. 
 
2. Elucidation of the release mechanism 
Function of PLGA  
For the three spray-dried API/PLGA samples the presence of one mixing Tg confirmed the 
presence of drug in the PLGA matrix as a glass solution. The observed mixing Tg increased 
with increasing API content. This is in agreement with the Gordon-Taylor equation which 
states that if the weight percentage of this compound increases, the mixing Tg shifts towards 
the Tg of the compound having the highest Tg. Therefore an increase in the amount of API (Tg 
56°C) versus the amount of PLGA (Tg 38°C) results in an augmented value for the observed 
mixing Tg.  
These samples showed a very restricted drug release (4.9% after four hours), which is not 
surprising because this water-insoluble polymer is well established as a matrix for sustained 
release, formulations.1-3 
 
Function of PVP 
For the three spray-dried API/PVP samples the presence of one mixing Tg confirmed that the 
drug was present in the PVP matrix as a glass solution. The observed mixing Tg decreased 
with increasing API content. This again correlates with the Gordon-Taylor equation which 
predicts a lowered value for the observed mixing Tg if the amount of API (Tg 56°C) increases.  
The molecular dispersion of the drug increases its solubility and consequently increases its 
release.  
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The initial increase in drug release was the highest for the samples API/PVP 10/90 wt%. This 
can be explained by the fact that this formulation has the highest polymer to drug ratio which 
is known to have a beneficial influence upon drug solubility,32 and here consequently upon 
drug release. Solubility testing in the presence of PVP proved that API solubility increased 
with increasing PVP concentration and therefore the role of PVP in the ternary formulations is 
dual. Firstly PVP increases drug release via an increased drug solubility due to the molecular 
drug dispersion in this matrix. Secondly the presence of PVP has a beneficial effect on the 
drug solubility (Fig. 2, Supporting Information). 
A noteworthy difference between the release profiles of the spray-dried API/PVP and 
API/PLGA/PVP formulations on the one hand and the physical mixtures of API/PVP on the 
other hand is the absence of a burst release of the latter in contrast to the spray-dried samples. 
Hence, the observed burst release can be ascribed to the additional solubility enhancement 
from processing the drug as a solid dispersion. 
 
Release mechanism 
In a previous study we described how the spray-dried polymeric matrix evolves upon 
exposure to increased humidity.5 When exposed to increased humidity a rearrangement occurs 
whereby a decrease in PLGA present at the surface is observed, coupled with an increased 
presence of PVP. This knowledge combined with our current findings and additional release 
testing of binary API/PVP and API/PLGA formulations resulted in a hypothesis for the 
underlying release mechanism as illustrated schematically in Figure 8. 
It is postulated that in the investigated time frame (4 h) the release mechanism is dominated 
by fast PVP leaching from the small domains of PVP present in the PLGA layer due to the 
high solubility of PVP. The resulting pores in the PLGA surface layer allow further ingression 
of release medium followed by rapid dissolution of the molecularly dispersed API followed 
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by diffusion out of the microspheres. The observed differences in the PLGA surface layer, 
such as API surface enrichment, will therefore have no significant influence in this stage of 
the release.  
In general terms, these injectable formulations comprising of a combination of a water-soluble 
polymer (PVP) and a water-insoluble polymer (PLGA) was used. The water-soluble polymer 
increased the solubility of a poorly soluble API whereas the water-insoluble polymer assured 
the sustained release behaviour of the formulation. 
Combinations of water-soluble and water-insoluble polymers have already been reported for 
oral formulations. For example the combination of ethyl cellulose (EC), water-insoluble, and 
hydroxypropyl cellulose, water-soluble, for oral administration has been described with pore 
formation due to HPC leaching after immersion in aqueous media as driving force of drug 
release.33 These findings are in agreement with the release mechanism proposed in the present 
study of an injectable matrix for a poorly soluble drug. 
 
 
CONCLUSIONS 
This study demonstrated how formulation and process parameters influence the characteristics 
of spray-dried microspheres. Differences were observed for miscibility and heterogeneity of 
the samples, particle size and morphology as well as API surface coverage. Observed 
differences are likely due to changes in the droplet evaporation and the subsequent particle 
formation process. For the investigated spray drying parameters at their assessed levels, feed 
concentration is the parameter to be controlled most rigorously as a low feed concentration 
resulted in divergent particle size, particle shape, compound miscibility, phase heterogeneity 
and API surface coverage. Despite the observed differences, varying particle characteristics 
did not influence the release behaviour of the formulation studied. This is likely due to the 
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proposed release mechanism where the release is dominated by diffusion from the PVP layer 
through pores in the PLGA surface layer. Hence, for the timeframe tested, spray drying 
resulted in a formulation with robust drug release characteristics.  
Moreover, it was confirmed that the function of the PLGA in these formulations is to form a 
phase separated surface layer so as to assure the required slow release characteristics of the 
formulation, whereas the underlying PVP phase increases the solubility and hence dissolution 
rate of a poorly soluble drug by forming a solid dispersion. 
 
ACKNOWLEDGEMENTS  
P. Rombaut is acknowledged for technical support. 
 
REFERENCES 
[1] Twaites B, de las Heras Alarcón C, Alexander C. 2005. Synthetic polymers as drugs and 
therapeutics. J Mater Chem 15:441–455. 
[2] Rhee YS, Sohn M, Woo BH, Thanoo BC, Deluca PP, Mansour HM. 2011.  Sustained-
Release Delivery of Octreotide from Biodegradable Polymeric Microspheres. AAPS 
PharmSciTech 12:1293–1301. 
[3] Eerdekens M, Van Hove I, Remmerie B, Mannaert E. 2004. Pharmacokinetics and 
tolerability of long-acting risperidone in schizophrenia. Schizophr Res 70:91–100. 
[4] Meeus J, Chen X, Scurr D, Ciarnelli V, Amssoms K, Roberts CJ, Davies MC, Van den 
Mooter G. 2012. Nanoscale surface characterization and miscibility study of a spray-dried 
injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and 
polyvinylpyrrolidone. J Pharm Sci 101(9):3473–3485. 
[5] Meeus J, Scurr D, Amssoms K, Davies MC, Roberts CJ, Van den Mooter G. 2013. 
Surface characteristics of a spray-dried polymeric matrix consisting of PLGA and PVP: 
22 
 
Relating the influence of temperature and humidity to the thermal characteristics of these 
polymers. Mol Pharm 10(8):3213–3224. 
[6] Vehring R. 2008. Pharmaceutical particle engineering via spray drying. Pharm Res 25(5): 
999–1022. 
[7] Cal K, Sollohub K. Spray drying technique. 2010.  I: Hardware and process parameters.  J 
Pharm Sci 99(2):575–586. 
[8] Paudel A, Worku ZA, Meeus J, Guns S, Van den Mooter G. 2013. Manufacturing of solid 
dispersions of poorly water soluble drugs by spray drying: formulation and process 
considerations. Int J Pharm 453(1):253–84. 
[9] Nandiyanto ABD, Okuyama K. 2011. Progress in developing spray-drying methods for 
the production of controlled morphology particles: From the nanometer to submicrometer size 
ranges. Adv Powder Technol 22(1):1–19. 
[10] Elversson J, Millqvist-Fureby A, Alderborn G, Elofsson U. 2003. Droplet and particle 
size relationship and shell thickness of inhalable lactose particles during spray drying.  J 
Pharm Sci  92(4):900–910. 
[11] Wan F, Bohr A, Maltesen MJ, Bjerregaard S, Foged C, Rantanen J, Yang M. 2013. 
Critical solvent properties affecting the particle formation process and characteristics of 
celecoxib-loaded PLGA microparticles via spray-drying. Pharm Res 30(4):1065–1076. 
[12] Paudel A, Van den Mooter G. 2012. Influence of solvent composition on the miscibility 
and physical stability of naproxen/PVP K 25 solid dispersions prepared by cosolvent spray-
drying. Pharm Res 29(1):251–270. 
[13] Paudel A, Loyson Y, Van den Mooter G. 2013. An investigation into the effect of spray 
drying temperature and atomizing conditions on miscibility, physical stability, and 
performance of naproxen-PVP K 25 solid dispersions.  J Pharm Sci 102(4):1249–1267. 
23 
 
[14] Rizi K, Green RJ, Donaldson M, Williams AC. Production of pH-responsive 
microparticles by spray drying: investigation of experimental parameter effects on 
morphological and release properties.  J Pharm Sci 100(2):566–579. 
[15] Friesen DT, Shanker R, Crew, Smithey DT, Curatolo WJ, Nightingale JAS. 2002. 
Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. 
Mol Pharm 5(6):1003–1019. 
[16] Craig DQM. 2002. The mechanisms of drug release from solid dispersions in water-
soluble polymers. Int J Pharm 231(2):131–144. 
[17] Siepmann J, Faisant N, Aikiki J, Richard J, Benoit JP. 2004. Effect of the size of 
biodegradable microparticles on drug release: experiment and theory. J Control Release 96: 
123–134. 
[18] Berkland C, Kim K, Pack DW. 2003. PLG microsphere size controls drug release rate 
through several competing factors.  Pharm Res 20:1055–1062. 
[19] Klose D, Siepmann F, Elkharraz K, Krenzlin S, Siepmann J. 2006. How porosity and size 
affect the drug release mechanisms from PLGA-based microparticles. Int J Pharmaceut 
314:198–206. 
[20] Pikal M, Chang L, Tang X. 2004. Evaluation of glassy-state dynamics from the width of 
the glass transition: results from theoretical simulation of differential scanning calorimetry 
and comparisons with experiment. J Pharm Sci 93:981–994. 
[21] Brüning R, Sutton M. 1996. Fragility of glass-forming systems and the width of the glass 
transition, J Non-Cryst Solids 205-207:480–484. 
[22] Savin DA, Larson AM, Lodge TP. 2004. Effect of the composition on the width of the 
calorimetric glass transition in polymer-solvent and solvent-solvent mixtures. J Polym Sci 
Part B: Polym  Phys  42:1155–1163. 
24 
 
[23] Kaerger JS, Edge S, Price R. 2004. Influence of particle size and shape on flowability 
and compactibility of binary mixtures of paracetamol and microcrystalline cellulose. Eur J 
Pharm Sci 22(2–3):173–179. 
[24] Guo A, Beddow J, Vetter AF. 1985. A Simple Relationship Between Particle Shape 
Effects and Density, Flow Rate and Hausner Ratio. Powder Technol 43:279–284. 
[25] Fu X, Huck D, Makein L, Armstrong B, Willen U, Freeman T. 2012. Effect of particle 
shape and size on flow properties of lactose powders. Particuology 10(2):203–208. 
[26] Bodmeier R, McGinity JW. 1988. Solvent selection in the preparation of poly(D,L-
lactide) microspheres prepared by the solvent evaporation method. Int J Pharmceut 43:179–
186. 
[27] Dunn AS. 1990. Polymer chemistry, an introduction. 2nd edition. Stevens MP, editor, 
New York: Oxford University Press.  
[28] Shard AG, Davies MC, Li YX, Volland C, Kissel T. 1997. XPS and SSIMS analysis 
revealing surface segregation and short-range order in solid films of block copolymers of PEO 
and PLGA. Macromolecules 30:3051–3057. 
[29] Opdahl A, Phillips RA, Somorjai GA. 2002. Surface segregation of methyl side branches 
monitored by Sum Frequency Geeneration (SGF) vibrational spectroscopy for a series of 
random poly(ethylene-co-propylene) copolymers. J Phys Chem B 106:5212–5220. 
[30] Wang J, Woodcock SE, Buck SM, Chen C, Chen Z. 2001. Different surface restructuring 
behaviors of poly(methacrylate)s detected by SGF in water. J Am Chem Soc 123:9470–9471. 
[31] Thanki P, Dellacherie E, Six JL. 2006. Surface characteristics of PLA and PLGA films. 
Appl Surface Sci 253:2758–2764. 
[32] Verheyen S, Blaton N, Kinget R, Van den Mooter G. 2002. Mechanism of increased 
dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int 
J Pharm 249(1–2):45–58. 
25 
 
[33] Andersson H, Hjärtstam J, Stading M, von Corswant C, Larsson A. 2013. Effects of 
molecular weight on permeability and microstructure of mixed 
ethyl-hydroxypropyl-cellulose films. European Journal of Pharmaceutical Sciences 48:240–
248. 
  
26 
 
FIGURES 
 
 
 
 
Figure 1. Scanning electron micrographs of selected formulations spray-dried under various 
conditions, where a = Reference and b = Feed concentration of 1%. 
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Figure 2. MDSC of selected formulations spray-dried under various conditions, where a = 
Reference, b = Feed concentration 1%, c = Feed rate 10 mL/min, d = Inlet air temperature 
135°C. Tg values and width of the Tg range for these samples are reported in Table 2. 
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Figure 3. ToF-SIMS ion intensity maps of selected formulations spray-dried under various 
conditions, where A = Reference and B = Feed concentration 1% samples (4 × 4 mm² scan 
size). Panel a shows results of the total intensity signal. Panels b and c show negative polarity 
images of respectively API (m/z = 183, C5H11SO5-) and PLGA (m/z = 143, C6H7O4-). Panels d 
show the negative polarity overlay images (API in red, PLGA in green).  
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Figure 4. I. Histogram representing the intensity at m/z 183 (secondary ion indicative of API) 
for all formulations spray-dried under various conditions, where A =  Reference A, B = 
Reference B, C = Reference C, D = Feed concentration 1%, E = Feed concentration 10%, F = 
Inlet air temperature 95°C, E = Inlet air temperature 135°C, F = Atomising air pressure 1.0 
bar, G = Atomising air pressure 1.5 bar, H = Feed rate 2 mL/min, I = Feed rate 10 mL/min (1 
× 1 mm² scan size, n=4) 
II. Negative ToF-SIMS spectra at m/z 183 of selected samples. 
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Figure 5.  Release behaviour of selected spray-dried API/PLGA/PVP formulations. 
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Figure 6. MDSC of spray-dried binary API/polymer combinations.  
I. API/PLGA, II. API/PVP 
a. 10/90 wt%, b. 20/80 wt%, c. 30/70 wt% 
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Figure 7. Release behaviour of binary API/polymer combinations.  
I. Spray-dried API/PLGA, II. Spray-dried API/PVP, III. Physical mixture API/PVP. 
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Figure 8. Hypothesized release mechanism. PLGA in green, PVP in red and API in yellow. 
Left, before exposure to an aqueous release medium. Right, after exposure to an aqueous 
release medium. 
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Table 1. Overview of the spray drying parameters studied and the levels at which these 
parameters were evaluated. 
 
 
 
  
Parameter Inlet air temperature  
(°C) 
Feed concentration  
(%)
Feed rate 
(mL/min)
Atomising air 
pressure (bar)
Low level 95 1 2 1.00 
Middle level 115 5 6 1.25 
High level 135 10 10 1.50 
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Table 2. Tg values and width of the Tg range for samples spray-dried with varying process 
and formulation parameters. 
 
 
  
Sample Tg1  
(°C)
Width Tg1  
(°C)
Tg2  
(°C) 
Width Tg2  
(°C)
Reference A 44.5 3.2 104.6 27.8 
Reference B 44.9 3.3 106.0 29.3 
Reference C 44.7 3.8 104.4 27.7 
Feed concentration 1% 44.3 7.6 125.9 29.1 
Feed concentration 10% 45.4 2.8 104.1 21.3 
Feed rate  2 mL/min 44.2 4.3 103.9 29.6 
Feed rate 10 mL/min 43.5 4.6 106.1 36.5 
Inlet air temperature 95°C 44.2 4.0 103.6 28.6 
Inlet air temperature 135°C 44.9 3.4 105.7 28.3 
Atomising air pressure 1.0 bar 45.3 2.8 107.0 27.9 
Atomising air pressure  1.5 bar 43.3 6.0 106.0 36.6 
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SUPPORTING INFORMATION 
 
 
 
Figure 1. Negative ToF-SIMS spectra showing the markers for API (m/z = 183, C5H11SO5-), 
PLGA (m/z = 143, C6H7O4-) and PVP (m/z = 84, C5H8O-) 
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Figure 2. Solubility of the API in the presence of PVP K30. 
